You must log in to view this page.

Xilio Therapeutics Inc. – Ownership Summary

NASDAQ: XLO
Share price (6/29/26): $9.27
Market cap (6/29/26): $61.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Shannon James Samuel »

12/34/56

Bonstein Sara »

12/34/56

≥5% Ownership

Orbimed Advisors LLC »

SCHEDULE 13G

12/34/56

Point72 Asset Management, L.P. »

SCHEDULE 13G/A

12/34/56

SCHEDULE 13G/A

12/34/56

SCHEDULE 13G

12/34/56

Xilio Therapeutics Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Shannon James Samuel »

Bonstein Sara »

≥5% Ownership

Orbimed Advisors LLC »

Point72 Asset Management, L.P. »

Xilio Therapeutics Inc. – Ownership Summary